IRADIMED CORPORATION

NasdaqGM:IRMD 주식 보고서

시가총액: US$674.6m

IRADIMED 미래 성장

Future 기준 확인 3/6

IRADIMED은 연간 수입과 매출이 각각 15.5%와 13.9% 증가할 것으로 예상되고 EPS는 연간 14.6%만큼 증가할 것으로 예상됩니다.

주요 정보

15.5%

수익 성장률

14.6%

EPS 성장률

Medical Equipment 수익 성장17.0%
매출 성장률13.9%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트01 Nov 2024

최근 미래 성장 업데이트

Recent updates

IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

Aug 08
IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Feb 23
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Feb 07
Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Nov 06
Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

Oct 13
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Feb 05
At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y

Oct 10

IRadimed: Record Revenue Could Translate To Share Price Appreciation

Aug 23

Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

Aug 17
Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M

Jul 29

IRadimed: Reduce Equity Beta With Upside Capture

Jul 18

IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

Jul 13
IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Feb 05
At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Jan 12
Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

수익 및 매출 성장 예측

NasdaqGM:IRMD - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20269927N/AN/A1
12/31/20258121N/AN/A2
12/31/20247319N/AN/A2
9/30/202471191724N/A
6/30/202469191316N/A
3/31/202468181113N/A
12/31/20236617513N/A
9/30/20236316513N/A
6/30/20236015715N/A
3/31/20235614513N/A
12/31/20225313810N/A
9/30/20225013910N/A
6/30/20224812910N/A
3/31/202245101112N/A
12/31/20214291111N/A
9/30/20213861010N/A
6/30/202135588N/A
3/31/202132156N/A
12/31/202032156N/A
9/30/202034477N/A
6/30/202036589N/A
3/31/202039101011N/A
12/31/201939101010N/A
9/30/2019368910N/A
6/30/201934877N/A
3/31/201932766N/A
12/31/201830677N/A
9/30/201829555N/A
6/30/2018273N/A6N/A
3/31/2018252N/A5N/A
12/31/2017230N/A3N/A
9/30/2017221N/A4N/A
6/30/2017243N/A6N/A
3/31/2017295N/A7N/A
12/31/2016327N/A9N/A
9/30/2016358N/A10N/A
6/30/2016359N/A9N/A
3/31/2016338N/A9N/A
12/31/2015318N/A8N/A
9/30/2015265N/A4N/A
6/30/2015224N/A3N/A
3/31/2015193N/A3N/A
12/31/2014152N/A3N/A
9/30/2014152N/A4N/A
6/30/2014142N/A3N/A
3/31/2014122N/A2N/A
12/31/2013112N/A1N/A

애널리스트 미래 성장 예측

수입 대 저축률: IRMD 의 연간 예상 수익 증가율( 15.5% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: IRMD 의 연간 수익( 15.5% ) US 시장( 15.4% 보다 빠르게 성장할 것으로 예상됩니다. 15.4% 연간).

고성장 수익: IRMD 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: IRMD 의 수익(연간 13.9% ) US 시장( 9% 보다 빠르게 성장할 것으로 예상됩니다. 9% 연간).

고성장 수익: IRMD 의 수익(연간 13.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: IRMD 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y